Coherus BioSciences


Coherus is a leading pure-play, global biosimilar company that develops and commercializes high-quality therapeutics. CHS-1701 (pegfilgrastim biosimilar) is the furthest advanced of the late-stage clinical products. Biosimilars are intended for use in place of existing branded biologics to treat a range of often life-threatening conditions, with the potential to reduce costs and expand patient access.

Exhibitor Level: 
Bronze Level
Booth Number: 
Exhibitor Type: 
Biotechnology Pharmaceuticals